Everybody 12 /Case Studies 0 /Conferences 3 /FreeMind Elite 0 /FreeMind Elite 2024 0 /Job posting 0 /NDFS 2025 Presentations 0 /News 0 /Opinions 0 /Opportunities 0 /Presentations 0 /Uncategorized 9 /Webinars 0

How did pharma firms develop COVID-19 vaccine so quickly?

February 18, 2021/by Beth Zalcman

How will the new administration affect non-dilutive funding?

February 7, 2021/by Beth Zalcman

How COVID-19 raised the profile of non-dilutive funding

February 7, 2021/by Beth Zalcman

Inova Immunology Virtual Partnering

January 26, 2021/by Beth Zalcman

Inova Oncology Virtual Partnering

January 26, 2021/by Beth Zalcman

Opening Remarks at NDFS

January 21, 2021/by Beth Zalcman

BARDA at NDFS

January 21, 2021/by Beth Zalcman

NIDDK at NDFS

January 21, 2021/by Beth Zalcman

NIA at NDFS

January 21, 2021/by Beth Zalcman

NHLBI at NDFS

January 21, 2021/by Beth Zalcman

NCATS at NDFS

January 21, 2021/by Beth Zalcman

NIAID at NDFS

January 21, 2021/by Beth Zalcman

Recent Posts

Followon XSubscribeto RSS Feed

Reach out to us with your non-dilutive funding requirements

Skip to content